Business leaderJason Hope is a reknown activist investor who is in charge of the current anti-aging research funding. As exciting technological strides are made yearly, prominent discussions occur about using advanced technology to enhance the human body. One such debate is about the potential efficacy of stem cell therapy in preventing debilitating age-related diseases.
While some camps hail or protest stem cell therapy, truehearted philanthropist Jason Hope reinforces a more balanced perspective. About 20 years ago, scientists successfully extracted human embryonic stem cells and grew them in a lab setting. This significant feat showed promise for the treatment of many age-related ailments.
Unfortunately, nothing else was accomplished in bringing stem cells to the market. Despite all the buzz about stem cells, the business mentor, an entrepreneur and expert in anti-aging/longevity, takes a more thoughtful position. Jason Hope sees these advancements in stem cell research as an excellent first step but views the current progress in research as limited.
Hope is aware of the public’s fears of stem cell therapy and, therefore, advocates for thorough research. Hope views these slow advancements as imperative for building the safe, effective stem cell therapies we need (Facebook).
To support the research required to integrate stem cell treatments in medicine, Hope strongly backs the SENS(Strategies for Engineered Negligible Senescence) Organization. The aim is to create preventative measures for degenerative diseases like Parkinson’s. According to Jason Hope, research is slow, but that is required to form a solid foundation for stem cell treatment. The journey to full integration of stem cells is arduous but nonetheless worth the investment for Hope.